colchicine has been researched along with Agnogenic Myeloid Metaplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amariglio, N; Arostegui, JI; Cohen, R; Goldstein, I; Gonzalez-Roca, E; Hirshberg, A; Kukuy, O; Livneh, A; Nagar, M; Rechavi, G; Salomon, O; Schiby, G; Sharabi, Y; Shinar, Y; Shubman, O; Tohami, T | 1 |
| Wasserman, LR; Weinreb, N; Wittman, R; Yu, T | 1 |
2 other study(ies) available for colchicine and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Acquired familial Mediterranean fever associated with a somatic MEFV mutation in a patient with JAK2 associated post-polycythemia myelofibrosis.
Topics: Biopsy; Clone Cells; Colchicine; Cytoskeletal Proteins; Exons; Familial Mediterranean Fever; Female; Gout Suppressants; Humans; Janus Kinase 2; Middle Aged; Mutation; Polycythemia Vera; Polymorphism, Restriction Fragment Length; Primary Myelofibrosis; Pyrin | 2015 |
Secondary gout associated with chronic myeloproliferative disorders.
Topics: Aged; Allopurinol; Colchicine; Female; Gout; Humans; Leukemia, Myeloid; Male; Middle Aged; Myeloproliferative Disorders; Polycythemia; Polycythemia Vera; Primary Myelofibrosis | 1976 |